Biosense Webster announces FDA clearance

October 12, 2005

Diamond Bar, CA - October 12, 2005 - Biosense Webster, Inc. today announced that the company has received clearance by the U.S. Food and Drug Administration (FDA) for devices that aid electroanatomical mapping. The CARTOTM RMT Navigation System, NAVISTAR® RMT Steerable Tip Diagnostic Catheter, and REFSTARTM RMT Catheter with the QWIKPATCH® External Reference Patch products were all designed to integrate with the Niobe® Magnetic Navigation System designed by Stereotaxis, Inc. The clearance of these Biosense Webster products by the FDA provides electrophysiologists additional tools and maneuvering capabilities when using the Niobe® Magnetic Navigation System to allow doctors to steer a catheter remotely.

Electroanatomical mapping allows you to create a 3D map of the heart showing electrical activity. By developing the 3D map using the Biosense Webster technology, doctors are able to pinpoint the exact timing or voltage of the electrical signal which allows for a more timely diagnosis of the patient's irregular heart beat (arrhythmia).

"This advanced technology from Biosense Webster provides improved capabilities for magnetic maneuvering," said Gery F. Tomassoni, MD, Director, Central Baptist Hospital Cardiac Research, Lexington, Kentucky. "Doctors can now perform high-precision procedures, such as mapping potentially life-threatening arrhythmias, while lowering the risks of radiation exposure."

"We are very pleased with the FDA clearance. Our remote magnetic technology coupled with the Niobe® Navigation System marks the beginning of a whole new era of electrophysiological innovation," said Roy Tanaka, president of Biosense Webster.

The products cleared by the FDA include:

CARTOTM RMT System combines unparalleled accuracy and precision in electroanatomical mapping with a new level of navigational control. The integration of the highly advanced Niobe® Navigation technology will enable electrophysiologists to utilize the full feature set of the previously introduced CARTOTM XP System with the additional flexibility of remote operation.

NAVISTAR® RMT Catheters work with the CARTOTM RMT System to create highly accurate 3D electroanatomical maps. Electrophysiologists will now be able to steer the NAVISTAR® Catheter using the integrated Niobe® Navigation technology while visualizing it within the CARTOTM RMT System map image. A miniature location sensor is placed inside each catheter for real-time, high-resolution mapping.

REFSTARTM RMT Catheters provide a reliable reference point within the CARTOTM RMT System to ensure an accurate visual framework for mapping diagnostic operations.
About Biosense Webster
Biosense Webster Inc, a Johnson & Johnson Company, pioneered EP diagnostic catheters more than 30 years ago and continues to lead the industry as an innovative provider of advanced diagnostic, therapeutic, and mapping tools. As the leader in navigation systems, Biosense Webster's technology includes the largest installed base of navigation systems worldwide in leading hospitals and teaching institutions. With proprietary products such as the CARTOMERGETM Image Integration Software Module and the LASSO® Circular Variable Mapping Catheter, the company is changing the way electrophysiologists diagnose and treat arrhythmias.

Edelman Public Relations

Related Catheter Articles from Brightsurf:

Catheter ablation linked to reduced risk of dementia in patients with atrial fibrillation
People with atrial fibrillation have a reduced risk of dementia if they undergo a procedure called catheter ablation to restore the normal rhythm of their heart, according to a new study published in the European Heart Journal that analyses over 27,000 patients with newly diagnosed atrial fibrillation out of a population of nearly a million people.

New female external catheter technology reduces CAUTI by 50%
Hospital-wide introduction of new female external catheter technology halved the number of catheter-associated urinary tract infections (CAUTIs) according to new research presented last week in Philadelphia at the 46th Annual Conference of the Association for Professionals in Infection Control and Epidemiology (APIC).

Catheter ablation reduces dementia risk in A-Fib, heart disease patients more than medications
Study finds that performing catheter ablations on patients who suffer from both atrial fibrillation and carotid arterial disease reduces their risk of dementia and stroke compared to managing their care with medications.

Germ-fighting catheter coating may help prevent infections
In an innovation that may ultimately help to prevent deadly bloodstream infections, a team of biomedical engineers and infectious disease specialists at Brown University developed a coating to keep intravascular catheters from becoming a haven for harmful bacteria.

Annals of Internal Medicine embargoed news; Catheter ablation superior to standard drug
A meta-analysis of randomized controlled trials found that catheter ablation was superior to conventional drug therapy alone for patients with atrial fibrillation and heart failure.

Experts strongly recommend catheter based closure for 'hole in the heart' patients
A catheter based procedure to close a type of 'hole in the heart' followed by antiplatelet drugs (e.g. aspirin) should be recommended for patients under 60 years old, who have also had a stroke, say a panel of experts in The BMJ today.

Foleys aren't fun: Patient study shows catheter risks
A new study puts large-scale evidence behind what many hospital patients already know: Having a urinary catheter may help empty the bladder, but it can hurt, lead to urinary tract infections, or cause other issues in the hospital and beyond.

Catheter ablation better than pharmacological atrial fibrillation therapies
A new study revealed patients receiving radiofrequency catheter ablation compared to traditional drug therapies for atrial fibrillation (AF), a contributing factor to heart failure, had significantly lower hospitalization and mortality rates.

A self-propelled catheter with earthworm-like peristaltic motion
A research team of Toho University and Tokyo Institute of Technology has developed a mechanism of a self-propelled catheter capable of generating peristaltic motion just like an earthworm by applying pneumatic pressure inside only one tube.

New cardiac catheter combines light and ultrasound to measure plaques
Biomedical engineers at UC Davis have combined intravascular ultrasound with fluorescence lifetime imaging in a single catheter probe that can image the tiny arteries of a living heart.

Read More: Catheter News and Catheter Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to